Point72 Asset Management, L.P. - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 101 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q4 2019$131,000
-93.1%
2,100
-95.5%
0.00%
-90.0%
Q2 2019$1,906,00046,8260.01%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q3 2019
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 3,037,042$236,950,0008.05%
MPM BioImpact LLC 269,186$21,002,0003.45%
Logos Global Management LP 400,000$31,208,0002.62%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 121,541$9,481,0002.50%
Orbimed Advisors 2,361,327$184,231,0001.86%
First Light Asset Management, LLC 395,825$30,882,0001.85%
SECTORAL ASSET MANAGEMENT INC 211,650$16,513,0001.34%
Nicholas Investment Partners, LP 224,876$17,545,0001.10%
DAFNA Capital Management LLC 47,852$3,733,0000.78%
Eventide Asset Management 578,000$45,096,0000.61%
View complete list of TURNING POINT THERAPEUTICS I shareholders